To elucidate the molecular link between the activation of the Src-related oncogenic pathway and mTOR-mediated tumor progression, we investigated the expression of mTOR complex components and the activity of downstream signaling molecules in human colon and prostate cancer cells in which the Src pathway is activated. The gene discussed is SRC; the disease is prostate cancer.